跳至主要内容
临床试验/NCT02308436
NCT02308436撤回不适用

Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide: a Mono-centre, Not-controlled. Not Blinded, Not-randmised in Situ Study

Mibelle AG1 个研究点 分布在 1 个国家开始时间: 2015年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
Mibelle AG
试验地点
1
主要终点
Detection of Curolox peptide by mass spectroscopy

研究概览

简要总结

In vitro results showed a protective effect against acids for the mouthwash containing Curolox™ peptide. The goal of this in situ study is to detect the Curolox™ peptide under natural oral conditions on the tooth surface and to proof the in vitro results obtained. So far there are no effect and safety data of the Curolox™ mouthwash under natural oral conditions available.

详细描述

The primary objective of the study is the detection of the Curolox™ peptide on the bovine enamel sample (proof-of-concept) under in vivo conditions after rinsing with the peptide-containing mouth wash.

Secondary Objectives

The secondary objectives of the study are:

  1. safety and tolerance of the mouthwash in participants
  2. identification of the duration the Curolox™ peptide is present on the bovine tooth surface under in vivo conditions
  3. identification of the most effective mouthwash rinsing volume (2.5 mL or 5 mL)
  4. prophylactic effect of multiple applications of the mouthwash confirmation of the prophylactic effect of the Curolox™ peptide obtained in in vitro study

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Willing and able to understand and to follow the study procedures and instructions
  • •Willing to wear a dental appliance for 7 days
  • •Willing and able to attend the on-study visits
  • •Good oral hygiene throughout the study
  • •Written informed consent before participation in the study

排除标准

  • •Volunteer with an active periodontal disease or periodontal surgery < 1 year prior to study participation
  • •Volunteer with hypersensitive teeth or with any other (painful) oral pathology or defect
  • •Volunteer with an orthodontic appliance
  • •Volunteer undergoing a medical treatment
  • •Volunteer who is allergic to dental products
  • •Pregnant and lactating woman
  • •Concurrent participation in another clinical trial

研究组 & 干预措施

Candida Mouthwash with Curolox™ Peptide

Experimental

Repeated applications 2.5 ml or 5 ml twice daily

干预措施: Candida Mouthwash with Curolox™ Peptide (Device)

结局指标

主要结局

Detection of Curolox peptide by mass spectroscopy

时间窗: Immediately after rinsing with the mouthwash

The primary outcome is the detection of the Curolox™ peptide on the bovine enamel sample immediately after rinsing with the peptide-containing mouth wash by mass spectroscopy

次要结局

  • Detection of Curolox peptide by mass spectroscopy(12 hours, 24 hours, 48 hours, 96 hours)

研究者

发起方
Mibelle AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
1 期
Clinical and Microbiological Effects of a Mouthwash Containing Chlorine DioxideHalitosis
NCT00748943Tokyo Medical and Dental University15
已完成
不适用
Cordia Myxa on prevention the effect of mouthwashes fruits of stomatitis (mouth sores) in patients receiving chemotherapyOsteomathite.III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismD80-D89
IRCT20180511039610N2Ahvaz University of Medical Sciences60
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.0 Level: PT Classification code 10066995 Term: Alveolar osteitis System Organ Class: 10021881 - Infections and infestations
EUCTR2014-004682-24-FRPIERRE FABRE MEDICAMENT409
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.1Level: PTClassification code 10066995Term: Alveolar osteitisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2014-004682-24-EEInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.1Level: PTClassification code 10066995Term: Alveolar osteitisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2014-004682-24-LTInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414